Patients with schizophrenia (SCZ) represent a vulnerable population who have been
understudied in COVID-19 research. We aimed to establish whether health outcomes and …

Background There is limited information describing the presenting characteristics and
outcomes of patients with schizophrenia (SCZ) requiring hospitalization for coronavirus …

Objective Individuals with schizophrenia may be at an increased risk for COVID-19 morbidity
due to the disease characteristics. In this study, we aimed to explore the odds of significant …

''Is my son at risk in view of COVID-19?''A patient's mother contacted our Schizophrenia
Outpatient Clinic as soon as news about the coronavirus pandemic reached Brazilian …

Objective Schizophrenia has been associated with patients' poor quality of life, disability,
and hospitalization. As of today, evidence that highlights the association between …

Importance To date, the association of psychiatric diagnoses with mortality in patients
infected with coronavirus disease 2019 (COVID-19) has not been evaluated. Objective To …

As the global burden of mortality from COVID-19 continues to rise, an understanding of who
is most at risk of adverse outcomes is of paramount importance. Pre-existing …

BackgroundCOVID-19 was declared a pandemic in March 2020, by the World Health
Organization. The pandemic has had unprecedented worldwide implications, in particular …

The population with severe mental disorders (SMD) is a medically and socially vulnerable
group for a worse outcome in COVID-19. This population has been identified as high-risk …

Abstract The coronavirus disease-19 (COVID-19) global pandemic has already had an
unprecedented impact on populations around the world, and is anticipated to have a …